These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24279123)

  • 41. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI.
    Schelhorn J; Best J; Reinboldt MP; Dechêne A; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Magn Reson Imaging; 2015 Sep; 42(3):818-27. PubMed ID: 25515676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation.
    Böttcher J; Hansch A; Pfeil A; Schmidt P; Malich A; Schneeweiss A; Maurer MH; Streitparth F; Teichgräber UK; Renz DM
    Eur J Radiol; 2013 Nov; 82(11):1860-9. PubMed ID: 23932636
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY; Choi JY; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE; You YK; Kim DG; Jung ES
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiparametric Gd-EOB-DTPA magnetic resonance in diagnosis of HCC: dynamic study, hepatobiliary phase, and diffusion-weighted imaging compared to histology after orthotopic liver transplantation.
    Faletti R; Cassinis MC; Fonio P; Bergamasco L; Pavan LJ; Rapellino A; David E; Gandini G
    Abdom Imaging; 2015 Jan; 40(1):46-55. PubMed ID: 24965896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The predictive value of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced MRI imaging features combined with quantitative parameters for the pathologic grading of hepatocellular carcinoma].
    Hu MJ; Yu YX; Fan YF; Jiang YM; Hu S; Wang XM; Hu CH
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1299-1304. PubMed ID: 32375436
    [No Abstract]   [Full Text] [Related]  

  • 47. The diagnosis of hypovascular hepatic lesions showing hypo-intensity in the hepatobiliary phase of Gd-EOB- DTPA-enhanced MR imaging in high-risk patients for hepatocellular carcinoma.
    Nakamura S; Nouso K; Kobayashi Y; Shiraha H; Ohnishi H; Toshimori J; Kuwaki K; Hagihara H; Takayama H; Yamamoto K
    Acta Med Okayama; 2013; 67(4):239-44. PubMed ID: 23970322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.
    Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
    Medicine (Baltimore); 2017 Jul; 96(29):e7278. PubMed ID: 28723741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.
    Kunishi Y; Numata K; Morimoto M; Okada M; Kaneko T; Maeda S; Tanaka K
    AJR Am J Roentgenol; 2012 Jan; 198(1):106-14. PubMed ID: 22194485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.
    Briani C; Di Pietropaolo M; Marignani M; Carbonetti F; Begini P; David V; Iannicelli E
    J Gastrointest Cancer; 2018 Sep; 49(3):302-310. PubMed ID: 28547117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma.
    Li J; Li X; Weng J; Lei L; Gong J; Wang J; Li Z; Zhang L; He S
    Medicine (Baltimore); 2018 Dec; 97(52):e13964. PubMed ID: 30593219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T.
    Lim S; Kim YK; Park HJ; Lee WJ; Choi D; Park MJ
    J Magn Reson Imaging; 2014 May; 39(5):1238-45. PubMed ID: 24136725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images.
    Chang WC; Chen RC; Chou CT; Lin CY; Yu CY; Liu CH; Chou JM; Hsu HH; Huang GS
    Abdom Imaging; 2014 Dec; 39(6):1202-12. PubMed ID: 24869790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging and Multidetector-Row Computed Tomography for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Ye F; Liu J; Ouyang H
    Medicine (Baltimore); 2015 Aug; 94(32):e1157. PubMed ID: 26266348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
    Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.
    Joo I; Lee JM; Lee DH; Ahn SJ; Lee ES; Han JK
    J Magn Reson Imaging; 2017 Mar; 45(3):731-740. PubMed ID: 27474328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.
    Kogita S; Imai Y; Okada M; Kim T; Onishi H; Takamura M; Fukuda K; Igura T; Sawai Y; Morimoto O; Hori M; Nagano H; Wakasa K; Hayashi N; Murakami T
    Eur Radiol; 2010 Oct; 20(10):2405-13. PubMed ID: 20490505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.
    Kim SY; Wu EH; Park SH; Wang ZJ; Hope TA; Yee J; Zhao LQ; Chang WC; Yeh BM
    Abdom Radiol (NY); 2016 Aug; 41(8):1522-31. PubMed ID: 26971341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.